Latest News in the pharma Industry

All

Gamlen Tableting changes its name to Gamlen Instruments

Gamlen Tableting changes its name to Gamlen Instruments

16 May 2017

New company name reflects diverse market opportunities.

Read more 
Aptar Pharma’s electronic Lockout device approved by EMA

Aptar Pharma’s electronic Lockout device approved by EMA

16 May 2017

The e-Lockout device being the first and only fully integrated electronic nasal drug delivery device to be approved by a US or European regulatory authority.

Read more 
Cambrex invests to increase pilot-scale API capacity at its High Point, NC facility

Cambrex invests to increase pilot-scale API capacity at its High Point, NC facility

16 May 2017

Increases site’s reactor capacity by 30%.

Read more 
Catalent and Therachon to advance clinical development of innovative protein therapy for achondroplasia

Catalent and Therachon to advance clinical development of innovative protein therapy for achondroplasia

15 May 2017

Catalent Biologics will use its proprietary GPEx technology to produce different protein variants for Therachon,

Read more 
Merck launches industry's first off-the-shelf cell culture media for perfusion processes

Merck launches industry's first off-the-shelf cell culture media for perfusion processes

15 May 2017

Allows customers to achieve a more optimal output than they would using conventional batch or fed-batch processes.

Read more 
Research reveals manufacturers and contract packagers may miss serialization deadlines

Research reveals manufacturers and contract packagers may miss serialization deadlines

15 May 2017

Many companies currently unprepared because they lack the internal resources to devote to serialization.

Read more 
Positive results for Lilly's three Phase III studies of galcanezumab for the prevention of migraine

Positive results for Lilly's three Phase III studies of galcanezumab for the prevention of migraine

14 May 2017

Read more 
Genentech to present new data on personalized medicines and cancer immunotherapies

Genentech to present new data on personalized medicines and cancer immunotherapies

12 May 2017

New pivotal results for Perjeta and Alecensa demonstrating improvement over standards of care.

Read more 
Avastin as effective as Eylea for treating central retinal vein occlusion

Avastin as effective as Eylea for treating central retinal vein occlusion

12 May 2017

NIH-funded clinical trial shows use of either drug improved vision and had few side effects.

Read more 
Hikma receives CRL regarding its ANDA for generic Advair Diskus

Hikma receives CRL regarding its ANDA for generic Advair Diskus

11 May 2017

Company believes low likelihood of approval this year.

Read more 
Merck's Keytruda scores another FDA approval

Merck's Keytruda scores another FDA approval

11 May 2017

FDA approves Keytruda as first-line combination therapy with pemetrexed and carboplatin for patients with metastatic nonsquamous non-small cell lung cancer (NSCLC) irrespective of PD-L1 expression.

Read more 
Takeda terminates plans for Vaxem Hib launch in Japan

Takeda terminates plans for Vaxem Hib launch in Japan

11 May 2017

Discontinuation due to the vaccine supplier’s (GSK) decision to discontinue global production.

Read more